|
POLR2K expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.662100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.142400E-03 |
| Normal-vs-Stage2 |
4.274400E-02 |
| Normal-vs-Stage3 |
4.156000E-01 |
| Normal-vs-Stage4 |
4.054800E-01 |
| Stage1-vs-Stage2 |
7.232200E-01 |
| Stage1-vs-Stage3 |
8.912100E-02 |
| Stage1-vs-Stage4 |
3.227000E-01 |
| Stage2-vs-Stage3 |
3.185800E-01 |
| Stage2-vs-Stage4 |
4.528400E-01 |
| Stage3-vs-Stage4 |
9.019600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.736500E-03 |
| Normal-vs-AfricanAmerican |
8.550400E-04 |
| Normal-vs-Asian |
6.017000E-01 |
| Caucasian-vs-AfricanAmerican |
5.790400E-01 |
| Caucasian-vs-Asian |
4.824800E-01 |
| AfricanAmerican-vs-Asian |
2.595400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.951500E-04 |
| Normal-vs-Female |
9.210200E-02 |
| Male-vs-Female |
3.210000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.198000E-02 |
| Normal-vs-Extreme_Weight |
3.229900E-02 |
| Normal-vs-Obese |
1.319720E-02 |
| Normal-vs-Extreme_Obese |
6.936300E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.392800E-01 |
| Normal_Weight-vs-Obese |
9.389400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.184400E-01 |
| Extreme_Weight-vs-Obese |
9.932800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.774200E-01 |
| Obese-vs-Extreme_Obese |
1.854240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.221200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.288370E-02 |
| Normal-vs-Age(61-80Yrs) |
8.619400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.277400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.398400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.803400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.828360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.253600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.697630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.558800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.9854999999982E-05 |
| Normal-VS-Type2 PRCC |
3.435700E-02 |
| Normal-VS-KIRP CIMP |
1.671210E-01 |
| Normal-VS-Unclassified PRCC |
4.126100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.751600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.493600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.110200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.108400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.983200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.662600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.979500E-03 |
| Normal-vs-N1 |
4.532800E-01 |
| Normal-vs-N2 |
9.014600E-01 |
| N0-vs-N1 |
1.104840E-01 |
| N0-vs-N2 |
2.255000E-01 |
| N1-vs-N2 |
6.141800E-01 |
|
|
